Award
Award 75N91024P00630 — GENSCRIPT USA INC
- Awarded to
- GENSCRIPT USA INC
- Agency
- Department of Health and Human Services
- Estimated value
- $3,078,000
SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)
Key dates
- Award date
- September 24, 2024
- Performance start
- September 24, 2024
- Performance end
- September 23, 2027
Who is this buyer
Organization
Buying history
- Records6 total
- Opportunities / awards1 / 2
- Value range$0 – $3,078,000
- ActiveAugust 10, 2026 – October 20, 2026
What they buy
- Clinical (5)
- Administrative (1)
Set-asides used
- No Set aside used (1)
- Small Business Set Aside - Total (1)
Who holds their work today
- GENSCRIPT USA INC1 win · $3,078,000 · last September 24, 2024
- BRIGHAM & WOMENS HOSPITAL INC1 win · $0 · last April 16, 2021
Also open from this buyer
- NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”Due November 20, 2026 · Clinical
View source document →
Source link on usaspending.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 621511
- PSC
- 6505